Keyphrases
Acute Pain Episodes
100%
Sickle Cell Disease
50%
Eptifibatide
50%
Platelet Activation
16%
Chronic Inflammation
8%
CD40 Ligand (CD40L)
8%
Steady State
8%
Coagulation Activation
8%
Disease Complications
5%
Supplemental Oxygen
5%
Antiplatelet Agents
5%
Endothelial Activation Markers
5%
Leukocyte Proliferation
5%
Gentle Hydration
5%
Platelet-leukocyte Aggregates
5%
Glycoprotein IIb/IIIa Inhibitors
5%
Patient Relatives
5%
Platelets
5%
Inflammatory Mediators
5%
Pathophysiology
5%
Hypercoagulability
5%
Medicine and Dentistry
Sickle-Cell Disease
50%
Pain
50%
Eptifibatide
50%
Thrombocyte Activation
14%
Platelet
14%
CD40 Ligand
10%
Steady State
10%
Chronic Inflammation
10%
Patient with Sickle Cell Disease
10%
Narcotic Analgesic Agent
7%
Thrombocyte Function
7%
Glycoprotein IIb/IIIa Inhibitors
7%
Antiplatelet Drug
7%
Leukocyte
7%
Pathophysiology
7%
Pharmacology, Toxicology and Pharmaceutical Science
Sickle Cell Anemia
50%
Eptifibatide
50%
Pain
50%
CD40 Ligand
8%
Inflammation
8%
Chronic Inflammation
8%
Pathophysiology
5%
Fibrinogen Receptor
5%
Antithrombocytic Agent
5%